Vireo Growth Inc (OTCMKTS:VREOD) Short Interest Down 97.8% in June

Vireo Growth Inc (OTCMKTS:VREODGet Free Report) saw a significant decrease in short interest in the month of June. As of June 30th, there was short interest totaling 2 shares, a decrease of 97.8% from the June 15th total of 93 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average daily trading volume, of 36,649 shares, the days-to-cover ratio is presently 0.0 days.

Vireo Growth Stock Performance

Shares of Vireo Growth stock remained flat at $9.95 during trading on Friday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.84 and a current ratio of 1.20. The firm has a market capitalization of $450.88 million, a price-to-earnings ratio of -3.01 and a beta of 1.78. The stock’s 50-day moving average is $11.57 and its 200-day moving average is $13.60. Vireo Growth has a 12-month low of $8.91 and a 12-month high of $24.00.

Analyst Ratings Changes

Separately, Zacks Research upgraded shares of Vireo Growth to a “strong sell” rating in a report on Friday, June 5th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has a consensus rating of “Sell”.

Read Our Latest Stock Report on VREOD

Vireo Growth Company Profile

(Get Free Report)

Vireo Growth is a cannabis-focused company that develops and operates licensed cannabis cultivation, processing, and retail businesses in the United States. The company’s activities generally center on producing and distributing cannabis products for both medical and adult-use markets, depending on the laws of the states in which it operates.

Vireo Growth has pursued a multi-state strategy, with operations historically concentrated in select U.S. markets where cannabis is legal under state law.

Featured Articles

Receive News & Ratings for Vireo Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vireo Growth and related companies with MarketBeat.com's FREE daily email newsletter.